Literature DB >> 8983977

Characterization and developmental regulation of avian corneal beta-1,4-galactosyltransferase mRNA.

C X Cai1, E Gibney, M K Gordon, J K Marchant, D E Birk, T F Linsenmayer.   

Abstract

Corneal development involves the synthesis and assembly of a number of specialized extracellular matrices. These matrices have distinctive properties derived from a unique assembly of collagens, proteoglycans and glycoproteins. The synthesis of each of these requires a number of enzymes. By probing a corneal cDNA library for genes that appeared to be up-regulated in cornea we have isolated a cDNA that represents an mRNA encoding the enzyme beta-1,4-galactosyltransferase. In cornea, a major function for this enzyme is likely to be in the synthesis of the keratan sulfate proteoglycan, lumican. Employing quantitative reverse transcript-polymerase chain reaction, we have observed that the steady-state level of mRNA for the molecule is elevated during certain stages of corneal development. It is also elevated in corneal fibroblasts in culture that have a greatly decreased synthesis of the mature lumican molecule. These data are consistent with, and complement, studies by others that show a corresponding regulation of the lumican core protein during development and in corneal fibroblast cultures.

Mesh:

Substances:

Year:  1996        PMID: 8983977     DOI: 10.1006/exer.1996.0108

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  3 in total

1.  A synchrotron x-ray diffraction study of developing chick corneas.

Authors:  A J Quantock; S Kinoshita; M S Capel; D J Schanzlin
Journal:  Biophys J       Date:  1998-02       Impact factor: 4.033

Review 2.  Keratan sulfate biosynthesis.

Authors:  James L Funderburgh
Journal:  IUBMB Life       Date:  2002-10       Impact factor: 3.885

Review 3.  Structural and biochemical aspects of keratan sulphate in the cornea.

Authors:  Andrew J Quantock; Robert D Young; Tomoya O Akama
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.